Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Human Molecular Genetics

• Publication date

  2006-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDI476PMID 16403807
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Centrosomal Microtubule Nucleation Activity Is Inhibited by BRCA1-Dependent Ubiquitination

  2005cited by this paper
• Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral

  2005cited by this paper
• BRCA1/BARD1 Ubiquitinate Phosphorylated RNA Polymerase II*

  2005cited by this paper
• BRCA1 participates in DNA decatenation

  2005cited by this paper
• Ubiquitin and ubiquitin-like proteins as multifunctional signals

  2005cited by this paper
• BRCA1-Dependent Ubiquitination of γ-Tubulin Regulates Centrosome Number

  2004cited by this paper
• BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.

  2004cited by this paper
• BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number.

  2004cited by this paper
• BRCA1 and BRCA2 mutations in women with familial or early‐onset breast/ovarian cancer in the Czech Republic

  2004cited by this paper
• Analysis of missense variation in human BRCA1 in the context of interspecific sequence variation

  2004influential reference
• BRCA1 and BRCA2: 1994 and beyond

  2004cited by this paper
• Solution structure of the ubiquitin-conjugating enzyme UbcH5B.

  2004influential reference
• Molecular analysis of the APC and MYH genes in Czech families affected by FAP or multiple adenomas: 13 novel mutations

  2004cited by this paper
• Regulation of tumor suppressors by nuclear-cytoplasmic shuttling.

  2003cited by this paper
• Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein*

  2003influential reference
• Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex

  2003influential reference
• Identification of Residues Required for the Interaction of BARD1 with BRCA1*

  2002cited by this paper
• Herpes Simplex Virus Type 1 Immediate-Early Protein ICP0 and Its Isolated RING Finger Domain Act as Ubiquitin E3 Ligases In Vitro

  2002cited by this paper
• Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains

  2002cited by this paper
• The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript

  2001cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001influential reference
• BRCA1 RING Domain Cancer-predisposing Mutations

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

  2001cited by this paper
• Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development

  2001cited by this paper
• Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1

  2001cited by this paper
• BRCA1 Physically and Functionally Interacts with ATF1*

  2000cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

  2000cited by this paper
• Identification of missense and truncating mutations in the BRCA1 gene in sporadic and familial breast and ovarian cancer

  1998influential reference
• BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression

  1998cited by this paper
• SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling

  1997cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• A positive genetic selection for disrupting protein-protein interactions: identification of CREB mutations that prevent association with the coactivator CBP.

  1996cited by this paper

• Study on the correlation between BRCA1 gene polymorphism and hrHPV infection in cervical precancerous lesions.

  2025cites this paper
• Functional characterization of BRCA1 variants of unknown significance using homologous recombination repair assays

  2025cites this paper
• The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome

  2024cites this paper
• Identification of Novel Functional Single Nucleotide Polymorphisms in the BRCA1 Gene of Breast Cancer Patients

  2024cites this paper
• Comparison of BRCA1 Gene Expression and CA15-3 Tumor Marker Level in Different Stages of Breast Cancer

  2024cites this paper
• Finding significance: New perspectives in variant classification of the RAD51 regulators, BRCA2 and beyond.

  2023cites this paper
• Functional Analyses of Rare Germline Missense BRCA1 Variants Located within and outside Protein Domains with Known Functions

  2023cites this paper
• BRCA1 Variant Assessment Using a Simple Analytic Assay.

  2022cites this paper
• Differential requirement for BRCA1-BARD1 E3 ubiquitin ligase activity in DNA damage repair and meiosis in the Caenorhabditis elegans germ line

  2022cites this paper
• Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.

  2022cites this paper
• Pathogenic BRCA1 variants disrupt PLK1-regulation of mitotic spindle orientation

  2022cites this paper
• Acetylation, Phosphorylation, Ubiquitination (Oh My!): Following Post-Translational Modifications on the Ubiquitin Road

  2022cites this paper
• The functional impact of BRCA1 BRCT domain variants using multiplexed DNA double-strand break repair assays.

  2022cites this paper
• Functional evidence (II) protein and enzyme function

  2021cites this paper
• Exploring absent protein function in yeast: assaying post translational modification and human genetic variation

  2021cites this paper
• Human BRCA1-BARD1 Ubiquitin ligase activity counters chromatin barriers to DNA resection

  2021cites this paper
• A synergetic effect of BARD1 mutations on tumorigenesis

  2021cites this paper
• Single nucleotide polymorphisms in breast cancer susceptibility gene 1 are associated with susceptibility to lung cancer.

  2021cites this paper
• The BRCA1/BARD1 ubiquitin ligase and its substrates.

  2021cites this paper
• Variants of uncertain clinical significance in hereditary breast and ovarian cancer genes: best practices in functional analysis for clinical annotation

  2020cites this paper
• Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer

  2020cites this paper
• The implication of the SUMOylation pathway in breast cancer pathogenesis and treatment

  2020cites this paper
• Characterizing BRCA1 Variants Using Multiplex Functional Assays

  2019cites this paper
• Impact of amino acid substitutions at secondary structures in the BRCT domains of the tumor suppressor BRCA1: Implications for clinical annotation

  2019cites this paper
• GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes

  2019influential citation
• A Novel Mutation-BRCA1 Associated Hereditary Haplotype of Intragenic Markers of BRCA1 Gene in a Family with History of Breast Cancer

  2019cites this paper
• BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes

  2018cites this paper
• Hierarchical core decomposition of RING structure as a method to capture novel functional residues within RING-type E3 ligases: a structural systems biology approach

  2018cites this paper
• Silibinin to improve cancer therapeutic, as an apoptotic inducer, autophagy modulator, cell cycle inhibitor, and microRNAs regulator

  2018cites this paper
• Detection of a novel mutations in Exon 11 of BRCA1 gene in the patients with hereditary breast cancer

  2018cites this paper
• BARD1 Gene Polymorphisms Confer Nephroblastoma Susceptibility

  2017cites this paper
• Characterization of a new BRCA1 rearrangement in an Italian woman with hereditary breast and ovarian cancer syndrome

  2017cites this paper
• 53BP1 regulates dna double-strand break repair in a mouse “BRCA-like” model by a non-resection mechanism

  2017cites this paper
• “Biological significance of germline alterations in BRCA1 and BRCA2 genes and response to DNA damage agents in hereditary breast cancer”

  2017cites this paper
• The Association between GWAS-identified BARD1 Gene SNPs and Neuroblastoma Susceptibility in a Southern Chinese Population

  2016cites this paper
• Human BRCA1–BARD1 ubiquitin ligase activity counteracts chromatin barriers to DNA resection

  2016cites this paper
• UBXD Proteins: A Family of Proteins with Diverse Functions in Cancer

  2016cites this paper
• Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.

  2016cites this paper
• Beyond DNA: An Integrated and Functional Approach for Classifying Germline Variants in Breast Cancer Genes

  2016cites this paper
• A BRCA1 deficient, NFκB driven immune signal predicts good outcome in triple negative breast cancer

  2016cites this paper
• JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer

  2016cites this paper
• A BRCA 1 deficient , NFκB driven immune signal predicts good outcome in triple negative breast cancer

  2016cites this paper
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016influential citation
• Síndrome de cáncer de mama y ovario hereditario: Estudio in vitro de variantes BRCA1 y BRCA2 de significado biológico desconocido y búsqueda de nuevos genes responsables de este síndrome

  2016cites this paper
• Human BRCA1-BARD1 Ubiquitin ligase activity counters chromatin barriers to DNA 3 resection.

  2016cites this paper
• The Role of BRCT-Containing Proteins BRCA1 and PAXIP1 in Cancer

  2015influential citation
• BRCA1 Circos: a visualisation resource for functional analysis of missense variants

  2015influential citation
• MCC inhibits beta‐catenin transcriptional activity by sequestering DBC1 in the cytoplasm

  2015cites this paper
• Massively Parallel Functional Analysis of BRCA1 RING Domain Variants

  2015influential citation
• The expanding role of yeast in cancer research and diagnosis: insights into the function of the oncosuppressors p53 and BRCA1/2.

  2014cites this paper
• Peto's Paradox and the Evolution of Cancer Suppression

  2014cites this paper
• Multifactorial Likelihood Assessment of BRCA1 and BRCA2 Missense Variants Confirms That BRCA1:c.122A>G(p.His41Arg) Is a Pathogenic Mutation

  2014influential citation
• The BRCA1 Variant p.Ser36Tyr Abrogates BRCA1 Protein Function and Potentially Confers a Moderate Risk of Breast Cancer

  2014cites this paper
• High prevalence of BRCA1 founder mutations in Greek breast/ovarian families

  2014cites this paper
• Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1

  2014cites this paper
• BRCA1 Haploinsufficiency Leads to Altered Expression of Genes Involved in Cellular Proliferation and Development

  2014cites this paper
• BRCA1 in the DNA damage response and at telomeres

  2013cites this paper
• Analysis of BRCA1 Variants in Double‐Strand Break Repair by Homologous Recombination and Single‐Strand Annealing

  2013influential citation
• A high-throughput functional complementation assay for classification of BRCA1 missense variants.

  2013cites this paper
• RNF111-dependent neddylation activates DNA damage-induced ubiquitination.

  2013cites this paper
• Validation of a Gene-Expression Based Assay for BRCA1 Function

  2013cites this paper
• A guide for functional analysis of BRCA1 variants of uncertain significance

  2012cites this paper
• The PDZ-binding motif of MCC is phosphorylated at position -1 and controls lamellipodia formation in colon epithelial cells.

  2012cites this paper
• Functional Characterization of Residues Required for the Herpes Simplex Virus 1 E3 Ubiquitin Ligase ICP0 To Interact with the Cellular E2 Ubiquitin-Conjugating Enzyme UBE2D1 (UbcH5a)

  2012cites this paper
• A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer

  2012cites this paper
• BRCA1 tumor suppressor network: focusing on its tail

  2012cites this paper
• Functional differences among BRCA1 missense mutations in the control of centrosome duplication

  2012influential citation
• DNA damage: placing BRCA1 in the proper context.

  2012cites this paper
• Unclassified variants in BRCA genes: guidelines for interpretation.

  2011cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

  2011cites this paper
• In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein

  2011cites this paper
• Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature

  2011cites this paper
• Assessment of human nter and cter BRCA1 mutations using growth and localization assays in yeast

  2011influential citation
• A DNA Repair Protein BRCA1 as a Potentially Molecular Target for the Anticancer Platinum Drug Cisplatin

  2011cites this paper
• Degradation‐linked ubiquitin signal and proteasome are integral components of DNA double strand break repair: New perspectives for anti‐cancer therapy

  2011cites this paper
• Small ubiquitin-related modifier-1: Wrestling with protein regulation.

  2011cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA 1 / BRCA 2 databases

  2011cites this paper
• Combinatorial Approaches to Study Protein Stability: Design and Application of Cell-Based Screens to Engineer Tumor Suppressor Proteins

  2011cites this paper
• The Role of BRCA1 Domains and Motifs in Tumor Suppression

  2011cites this paper
• The BRCA1 ubiquitin ligase and homologous recombination repair

  2011cites this paper
• Epigenetic tumor suppression by BRCA1

  2011cites this paper
• The "Mutated in Colorectal Cancer" Protein Is a Novel Target of the UV-Induced DNA Damage Checkpoint.

  2010cites this paper
• The Clinical Significance of Unknown Sequence Variants in BRCA Genes

  2010cites this paper
• Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer

  2010cites this paper
• Connecting the Dots: Interplay between Ubiquitylation and SUMOylation at DNA Double-Strand Breaks.

  2010cites this paper
• DNA double-strand break signaling and human disorders

  2010cites this paper
• Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination.

  2010cites this paper
• Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

  2010cites this paper
• A PIAS-ed view of DNA double strand break repair focuses on SUMO.

  2010cites this paper
• More modifiers move on DNA damage.

  2010cites this paper
• Characterization of BRCA1 ring finger variants of uncertain significance

  2010cites this paper
• Functional Analysis of Familial Asp67Glu and Thr1051Ser BRCA1 Mutations in Breast/Ovarian Carcinogenesis

  2009cites this paper
• Unclassified Variants in the Breast Cancer Susceptibility Genes BRCA1 and BRCA2

  2009cites this paper
• A common Greenlandic Inuit BRCA1 RING domain founder mutation

  2009cites this paper
• BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment

  2009cites this paper
• The role of BACH1 , BARD1 and TOPBP1 genes in familial breast cancer

  2009cites this paper
• The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress

  2009cites this paper
• Recent Advances in Understanding the Cellular Functions of BRCA1

  2009cites this paper
• BRCA1: a new genomic marker for non-small-cell lung cancer.

  2008cites this paper
• The Helicase-Like Transcription Factor and its implication in cancer progression

  2008cites this paper